Compare AMAR REMEDIES with Colgate - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 47.4 - View Chart
P/BV x 0.1 28.7 0.2% View Chart
Dividend Yield % 0.0 1.5 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-19
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1641,365 12.0%   
Low Rs861,020 8.4%   
Sales per share (Unadj.) Rs261.6164.1 159.5%  
Earnings per share (Unadj.) Rs17.428.5 61.0%  
Cash flow per share (Unadj.) Rs22.334.4 64.8%  
Dividends per share (Unadj.) Rs023.00 0.0%  
Dividend yield (eoy) %01.9 0.0%  
Book value per share (Unadj.) Rs100.753.2 189.4%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.3 6.6%   
Avg P/E ratio x7.241.8 17.2%  
P/CF ratio (eoy) x5.634.7 16.2%  
Price / Book Value ratio x1.222.4 5.5%  
Dividend payout %080.7 0.0%   
Avg Mkt Cap Rs m3,270324,389 1.0%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m1632,959 5.5%   
Avg. sales/employee Rs ThNM19,359.8-  
Avg. wages/employee Rs ThNM1,283.7-  
Avg. net profit/employee Rs ThNM3,364.7-  
INCOME DATA
Net Sales Rs m6,84444,624 15.3%  
Other income Rs m21377 5.6%   
Total revenues Rs m6,86545,001 15.3%   
Gross profit Rs m1,13112,361 9.2%  
Depreciation Rs m1281,592 8.0%   
Interest Rs m39825 1,592.0%   
Profit before tax Rs m62611,121 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50305 -16.4%   
Tax Rs m1213,670 3.3%   
Profit after tax Rs m4557,756 5.9%  
Gross profit margin %16.527.7 59.7%  
Effective tax rate %19.333.0 58.6%   
Net profit margin %6.617.4 38.3%  
BALANCE SHEET DATA
Current assets Rs m4,90410,102 48.5%   
Current liabilities Rs m3,58110,511 34.1%   
Net working cap to sales %19.3-0.9 -2,106.9%  
Current ratio x1.41.0 142.5%  
Inventory Days Days12420 611.2%  
Debtors Days Days10017 583.7%  
Net fixed assets Rs m1,68913,896 12.2%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,35814,196 16.6%   
Net worth Rs m2,63514,468 18.2%   
Long term debt Rs m507777 65.2%   
Total assets Rs m6,86226,265 26.1%  
Interest coverage x2.6445.8 0.6%   
Debt to equity ratio x0.20.1 358.2%  
Sales to assets ratio x1.01.7 58.7%   
Return on assets %12.429.6 42.0%  
Return on equity %17.353.6 32.2%  
Return on capital %31.075.1 41.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2732,007 13.6%   
Fx outflow Rs m27,191 0.0%   
Net fx Rs m271-5,184 -5.2%   
CASH FLOW
From Operations Rs m-3139,830 -3.2%  
From Investments Rs m-489-957 51.0%  
From Financial Activity Rs m769-8,147 -9.4%  
Net Cashflow Rs m-33726 -4.5%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   HUL  P&G HYGIENE  LINC PEN & PLASTICS  GODREJ INDUSTRIES  JYOTHY LABS  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

COLGATE Announces Quarterly Results (2QFY21); Net Profit Up 12.3% (Quarterly Result Update)

Oct 22, 2020 | Updated on Oct 22, 2020

For the quarter ended September 2020, COLGATE has posted a net profit of Rs 3 bn (up 12.3% YoY). Sales on the other hand came in at Rs 13 bn (up 6.0% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (1QFY21); Net Profit Up 17.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, COLGATE has posted a net profit of Rs 2 bn (up 17.2% YoY). Sales on the other hand came in at Rs 10 bn (down 4.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (4QFY20); Net Profit Up 3.3% (Quarterly Result Update)

May 27, 2020 | Updated on May 27, 2020

For the quarter ended March 2020, COLGATE has posted a net profit of Rs 2 bn (up 3.3% YoY). Sales on the other hand came in at Rs 11 bn (down 7.1% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (3QFY20); Net Profit Up 3.6% (Quarterly Result Update)

Jan 31, 2020 | Updated on Jan 31, 2020

For the quarter ended December 2019, COLGATE has posted a net profit of Rs 2 bn (up 3.6% YoY). Sales on the other hand came in at Rs 11 bn (up 4.3% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (2QFY20); Net Profit Up 24.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, COLGATE has posted a net profit of Rs 2 bn (up 24.3% YoY). Sales on the other hand came in at Rs 12 bn (up 3.9% YoY). Read on for a complete analysis of COLGATE's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS